EGALET AS has a total of 47 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and medical technology are EGALET LTD, GUIYANG XIN TIAN PHARMACEUTICAL CO LTD and LABORATEC S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | EPO (European Patent Office) | 13 | |
#3 | United States | 7 | |
#4 | Canada | 6 | |
#5 | Israel | 3 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Bar-Shalom Daniel | 35 |
#2 | Slot Lillian | 27 |
#3 | Fischer Gina | 22 |
#4 | Lademann Anne-Marie | 16 |
#5 | Andersen Christine | 15 |
#6 | Lindhardt Karsten | 7 |
#7 | Lyhne-Iversen Louise Inoka | 6 |
#8 | Olsen Martin Rex | 6 |
#9 | Haahr Anne-Mette | 6 |
#10 | Jensen Christine | 5 |
Publication | Filing date | Title |
---|---|---|
WO2010149169A2 | Controlled release formulations | |
CA2750400A1 | Controlled release formulations with continuous efficacy | |
HK1120403A1 | Matrix compositions for controlled delivery of drug substances | |
US2010291205A1 | Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse | |
EP1610767A1 | Morphine controlled release system | |
EP1974726A2 | Matrix compositions for controlled delivery of drug substances | |
AU2003275953A1 | Controlled release carvedilol compositions | |
EP1429744A1 | Morphine polymer release system | |
EP1929998A2 | Controlled release solid dispersions of carvedilol |